Glaukos (GKOS) Enterprise Value Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.76% |
| Dec 31, 2025 | 46.46% |
| Sep 30, 2025 | 1.89% |
| Jun 30, 2025 | -48.09% |
| Mar 31, 2025 | -168.86% |
| Dec 31, 2024 | -81.48% |
| Sep 30, 2024 | 8.07% |
| Jun 30, 2024 | 28.20% |
| Mar 31, 2024 | 44.38% |
| Dec 31, 2023 | 21.80% |
| Sep 30, 2023 | -4.72% |
| Jun 30, 2023 | 7.55% |
| Mar 31, 2023 | 28.06% |
| Dec 31, 2022 | -18.68% |
| Sep 30, 2022 | 8.06% |
| Jun 30, 2022 | 13.31% |
| Mar 31, 2022 | -9.91% |
| Dec 31, 2021 | -4.26% |
| Sep 30, 2021 | -39.68% |
| Mar 31, 2021 | 16.39% |
| Dec 31, 2020 | -54.73% |
| Sep 30, 2020 | -104.87% |
| Mar 31, 2020 | -243.14% |
| Dec 31, 2019 | -109.35% |
| Sep 30, 2019 | 64.92% |
| Jun 30, 2019 | -60.35% |
| Mar 31, 2019 | 66.34% |
| Dec 31, 2018 | -21.68% |
| Sep 30, 2018 | -483.41% |
| Jun 30, 2018 | -86.54% |
| Mar 31, 2018 | -1,056.72% |
| Dec 31, 2017 | -277.39% |
| Sep 30, 2017 | -287.29% |
| Jun 30, 2017 | -8.36% |
| Mar 31, 2017 | 16.75% |
| Dec 31, 2016 | 69.90% |
| Sep 30, 2016 | 94.66% |
| Jun 30, 2016 | 88.15% |
| Mar 31, 2016 | -145.15% |
| Dec 31, 2015 | -81.14% |
| Sep 30, 2015 | -4,213.26% |
| Jun 30, 2015 | -4,821.74% |
| Dec 31, 2014 | -77.01% |